Neurology · 1993 · 59 citations · 0 references
PharmacyPharmacologyPharmacotherapyEpilepsyNeonatologyPediatric PharmacotherapyInfant PharmacotherapyNeonatal Drug TherapyNeonatal PharmacologyNeonatal PharmacotherapyPediatric PharmacologySeizure ManagementDizygotic TwinsMonozygotic TwinsMyoclonic Seizure PharmacotherapyMyoclonic SeizuresNonketotic HyperglycinemiaSeizuresStatus Epilepticus CareStatus Epilepticus Pharmacotherapy
A 10-week-old girl with nonketotic hyperglycinemia was treated with increasing amounts of dextromethorphan, an NMDA receptor antagonist. She improved neurologically; at 35 mg/kg/d, seizures ceased and EEG normalized. Dextromethorphan withdrawal resulted in a dramatic clinical deterioration coinciding with epileptic and high-voltage slow activity in the EEG. After reintroduction of dextromethorphan (35 mg/kg/d), recovery occurred within 24 hours.